These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 22132771)

  • 21. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe.
    Schneider HP
    Int J Fertil Womens Med; 1997; 42 Suppl 2():365-75. PubMed ID: 9397384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy counseling: prevalence and predictors.
    Laborde J; Foley ME
    J Womens Health (Larchmt); 2002 Nov; 11(9):805-11. PubMed ID: 12626080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-reported data on reproductive variables were reliable among postmenopausal women.
    Lucas R; Azevedo A; Barros H
    J Clin Epidemiol; 2008 Sep; 61(9):945-50. PubMed ID: 18468857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why menopausal women do not want to take hormone replacement therapy.
    Rabin DS; Cipparrone N; Linn ES; Moen M
    Menopause; 1999; 6(1):61-7. PubMed ID: 10100182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of hormone replacement therapy on insulin resistance and platelet function tests.
    Saraç F; Saydam G; Sahin F; Oztekin K; Saygili F; Tüzün M; Yilmaz C
    Med Princ Pract; 2009; 18(1):43-7. PubMed ID: 19060490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function.
    Huang KE; Xu L; I NN; Jaisamrarn U
    Maturitas; 2010 Mar; 65(3):276-83. PubMed ID: 20018469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression and lipoprotein lipids in healthy, postmenopausal women; the moderating effects of hormone replacement therapy.
    Brown RA; Giggey PP; Dennis KE; Waldstein SR
    J Psychosom Res; 2004 Aug; 57(2):171-6. PubMed ID: 15465072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Background factors influencing somatic and psychological symptoms in middle-age women with different hormonal status. A population-based study of Swedish women.
    Li C; Borgfeldt C; Samsioe G; Lidfeldt J; Nerbrand C
    Maturitas; 2005; 52(3-4):306-18. PubMed ID: 15967603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of hormone replacement therapy by postmenopausal women in the United States.
    Keating NL; Cleary PD; Rossi AS; Zaslavsky AM; Ayanian JZ
    Ann Intern Med; 1999 Apr; 130(7):545-53. PubMed ID: 10189323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canadian menopause study-I: Understanding women's intentions to utilise hormone replacement therapy.
    Fisher WA; Sand M; Lewis W; Boroditsky R
    Maturitas; 2000 Nov; 37(1):1-14. PubMed ID: 11099868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do perceptions of risk and quality of life affect use of hormone replacement therapy by postmenopausal women?
    Scheid DC; Coleman MT; Hamm RM
    J Am Board Fam Pract; 2003; 16(4):270-7. PubMed ID: 12949027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of coronary heart disease, dietary fat modification, stages of change, and self-efficacy in surgically and naturally postmenopausal women.
    Schwab ND
    J Womens Health Gend Based Med; 2000 Dec; 9(10):1089-99. PubMed ID: 11153105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of Initiating Hormone Replacement Therapy in Postmenopausal Women: A Cross-Sectional Study.
    Çilgin H
    ScientificWorldJournal; 2019; 2019():1814804. PubMed ID: 30728754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Knowledge of hormone replacement therapy among menopausal women].
    Ruiz I; Bermejo MJ
    Gac Sanit; 2004; 18(1):32-7. PubMed ID: 14980170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of the intention to adopt hormone replacement therapy among premenopausal women.
    Légaré F; Godin G; Guilbert E; Laperrière L; Dodin S
    Maturitas; 2000 Mar; 34(3):211-8. PubMed ID: 10717486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menopausal experiences and hormone replacement therapy use among women with physical impairments.
    Becker H; Stuifbergen AK; Gordon D
    Womens Health Issues; 2002; 12(4):212-9. PubMed ID: 12093585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation.
    O'Connor AM; Tugwell P; Wells GA; Elmslie T; Jolly E; Hollingworth G; McPherson R; Bunn H; Graham I; Drake E
    Patient Educ Couns; 1998 Mar; 33(3):267-79. PubMed ID: 9731164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial differences in physician recommendation of hormone replacement therapy.
    Weng HH; McBride CM; Bosworth HB; Grambow SC; Siegler IC; Bastian LA
    Prev Med; 2001 Dec; 33(6):668-73. PubMed ID: 11716665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.